Search Results - A. Shablak
- Showing 1 - 1 results of 1
-
1
High-dose interleukin2 – a 10-year single-site experience in the treatment of metastatic renal cell carcinoma: careful selection of patients gives an excellent outcome by S. Chow, V. Galvis, M. Pillai, R. Leach, E. Keene, A. Spencer-Shaw, A. Shablak, J. Shanks, T. Liptrot, F. Thistlethwaite, R. E. Hawkins
Published in Journal for ImmunoTherapy of Cancer (2016-11-01)Get full text
Article
